GGHC
Gilder Gagnon Howe & Co Portfolio holdings
AUM
$9.42B
This Quarter Return
+3.93%
1 Year Return
+54.36%
3 Year Return
+272.74%
5 Year Return
+377.85%
10 Year Return
+3,143.71%
AUM
$5.36B
AUM Growth
+$5.36B
(-6.5%)
Cap. Flow
-$101M
Cap. Flow
% of AUM
-1.89%
Top 10 Holdings %
Top 10 Hldgs %
30.29%
Holding
272
New
25
Increased
53
Reduced
155
Closed
28
Top Buys
| 1 |
Canadian Pacific Kansas City
CP
|
$79.4M |
| 2 |
Meta Platforms (Facebook)
META
|
$51.1M |
| 3 |
Chart Industries
GTLS
|
$32.8M |
| 4 |
Wolfspeed
WOLF
|
$23.4M |
| 5 |
Madison Square Garden
MSGS
|
$23.2M |
Top Sells
| 1 |
Novo Nordisk
NVO
|
$53.7M |
| 2 |
Enphase Energy
ENPH
|
$35M |
| 3 |
Calix
CALX
|
$30.1M |
| 4 |
LFG
Archaea Energy Inc.
LFG
|
$29.8M |
| 5 |
Tesla
TSLA
|
$22.8M |
Sector Composition
| 1 | Technology | 32.99% |
| 2 | Healthcare | 19.84% |
| 3 | Consumer Discretionary | 17.94% |
| 4 | Industrials | 9.84% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RNLX
176
DELISTED
Renalytix plc American Depositary Shares
RNLX
| $1.89M | 0.04% |
1,009,083
-176,780
| -15% | -$331K |
|
177
iRhythm Technologies
IRTC
$5.46B
| $1.86M | 0.03% |
19,900
+8
| +0% | +$749 |
|
178
Garrett Motion
GTX
$2.62B
| $1.82M | 0.03% |
238,782
+87
| +0% | +$663 |
|
179
Liberty Energy
LBRT
$1.82B
| $1.75M | 0.03% |
+109,410
| New | +$1.75M |
|
|
AZUL
180
DELISTED
Azul
AZUL
| $1.62M | 0.03% |
264,730
-696,580
| -72% | -$4.26M |
|
181
Relay Therapeutics
RLAY
$619M
| $1.61M | 0.03% |
107,958
-35,562
| -25% | -$531K |
|
182
Insulet
PODD
$23.9B
| $1.55M | 0.03% |
5,272
+3
| +0.1% | +$883 |
|
|
ISEE
183
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.55M | 0.03% |
72,292
-33
| -0% | -$707 |
|
|
KRTX
184
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.49M | 0.03% |
7,571
-58
| -0.8% | -$11.4K |
|
|
ATVI
185
DELISTED
Activision Blizzard Inc.
ATVI
| $1.45M | 0.03% |
18,993
-1,146
| -6% | -$87.7K |
|
186
Salesforce
CRM
$245B
| $1.43M | 0.03% |
10,782
-5,976
| -36% | -$792K |
|
187
Crocs
CROX
$4.76B
| $1.41M | 0.03% |
+13,041
| New | +$1.41M |
|
188
Sherwin-Williams
SHW
$91.2B
| $1.38M | 0.03% |
5,795
+720
| +14% | +$171K |
|
189
Leslie's
LESL
$61.7M
| $1.37M | 0.03% |
111,885
-273,270
| -71% | -$3.34M |
|
190
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.34M | 0.02% |
4,327
-8
| -0.2% | -$2.47K |
|
191
Cytokinetics
CYTK
$4.23B
| $1.25M | 0.02% |
27,320
+1,485
| +6% | +$68K |
|
192
United Therapeutics
UTHR
$13.8B
| $1.24M | 0.02% |
+4,451
| New | +$1.24M |
|
193
Starbucks
SBUX
$100B
| $1.22M | 0.02% |
12,292
+2
| +0% | +$198 |
|
194
Aspen Aerogels
ASPN
$563M
| $1.19M | 0.02% |
100,828
-214
| -0.2% | -$2.52K |
|
195
A10 Networks
ATEN
$1.28B
| $1.18M | 0.02% |
+70,696
| New | +$1.18M |
|
196
CyberArk
CYBR
$22.8B
| $1.14M | 0.02% |
+8,794
| New | +$1.14M |
|
197
Veeva Systems
VEEV
$44B
| $1.07M | 0.02% |
6,653
-2
| -0% | -$323 |
|
|
RVNC
198
DELISTED
Revance Therapeutics, Inc.
RVNC
| $977K | 0.02% |
52,939
-3
| -0% | -$55 |
|
199
Penumbra
PEN
$10.6B
| $976K | 0.02% |
+4,387
| New | +$976K |
|
200
Sonos
SONO
$1.68B
| $945K | 0.02% |
55,933
-1,167
| -2% | -$19.7K |
|